Molly He, Ph.D. is a Senior Director of Scientific Research at Illumina, responsible for Illumina’s global protein reagent innovation and improvements. By leveraging state of the art protein engineering technologies and developing new tools, Molly’s organization has enabled faster, longer, less expensive and better sequencing. In addition, Molly is also interested in using Illumina’s sequencing platform as a high-throughput tool to understand biological problems and to develop new approaches to help other industries including Synthetic Biology and Pharma.
In her role at Illumina, Molly currently sponsors initiatives that encompass Research and Development, Operations, and Life Cycle Management, leading and growing scientific and technical teams in Singapore and the U.S. focused on enzyme reagent research and development.
Before Illumina, Molly was the Head of Protein Sciences at Pacific Biosciences responsible for protein reagent development for their single molecular real time sequencing chemistry. She also spent 10 years in the pharmaceutical industry focusing on structural based design of antibody and small molecule drugs targeting cancer and immune diseases.
Molly received her postdoc training in Structural Biology with Dr. Brian Matthews, and holds a Ph.D. from UCLA in protein biophysics. She has published more than twenty articles in high profile journals, including Science and Nature. She also holds more than twenty patent applications and issued patents in the field of next generation sequencing and personalized medicine.